ECM
PTCT icon

Element Capital Management’s PTC Therapeutics PTCT Stock Holding History

Element Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-88,244
Closed -$2.98M – 182
2019
Q3 		$2.98M Buy
+88,244
New +$3.84M 0.26% 87
2018
Q4 		– Sell
-6,299
Closed -$296K – 836
2018
Q3 		$296K Buy
+6,299
New +$261K 0.01% 599

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Element Capital Management's PTCT Position: Q4 2019 in Review

Element Capital Management sold out of PTC Therapeutics (PTCT) in Q4 2019, closing a stake of 88,244 shares — an estimated $2.98M sold.

Element Capital Management first reported a position in PTCT in Q3 2018 and held it in 2 quarters. The position peaked at $2.98M in Q3 2019. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • Element Capital Management reported no remaining PTC Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Element Capital Management sold 88,244 PTC Therapeutics shares in Q4 2019, an estimated $2.98M.
  • Element Capital Management first reported a position in PTC Therapeutics in Q3 2018 and held it in 2 quarters.
  • Element Capital Management's PTC Therapeutics position peaked at $2.98M in Q3 2019.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on Element Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.